BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1732513)

  • 1. Contribution of charged amino acids in the CDR2 region of CD4 to HIV-1 gp120 binding.
    Choe HR; Sodroski J
    J Acquir Immune Defic Syndr (1988); 1992; 5(2):204-10. PubMed ID: 1732513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis.
    Ashkenazi A; Presta LG; Marsters SA; Camerato TR; Rosenthal KA; Fendly BM; Capon DJ
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7150-4. PubMed ID: 2402498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human immunodeficiency virus gp120 binding site on CD4: delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high-resolution CD4 atomic structure.
    Moebius U; Clayton LK; Abraham S; Harrison SC; Reinherz EL
    J Exp Med; 1992 Aug; 176(2):507-17. PubMed ID: 1500858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A region in domain 1 of CD4 distinct from the primary gp120 binding site is involved in HIV infection and virus-mediated fusion.
    Truneh A; Buck D; Cassatt DR; Juszczak R; Kassis S; Ryu SE; Healey D; Sweet R; Sattentau Q
    J Biol Chem; 1991 Mar; 266(9):5942-8. PubMed ID: 1706342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a discontinuous epitope of the HIV envelope protein gp120 recognized by a human monoclonal antibody using chemical modification and mass spectrometric analysis.
    Hager-Braun C; Hochleitner EO; Gorny MK; Zolla-Pazner S; Bienstock RJ; Tomer KB
    J Am Soc Mass Spectrom; 2010 Oct; 21(10):1687-98. PubMed ID: 20434359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion.
    Broder CC; Berger EA
    J Virol; 1993 Feb; 67(2):913-26. PubMed ID: 8419649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and structural analysis of residues in the V1 region of CD4 involved in interaction with human immunodeficiency virus envelope glycoprotein gp120 and class II major histocompatibility complex molecules.
    Bowman MR; MacFerrin KD; Schreiber SL; Burakoff SJ
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):9052-6. PubMed ID: 1978941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of the gp120-binding area of murine and human CD4 molecules.
    Siddiqi MA; Tachibana M; Ohta S; Ikegami Y; Tahara-Hanaoka S; Huang YY; Shinohara N
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jan; 14(1):7-12. PubMed ID: 8989204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An efficient phage plaque screen for the random mutational analysis of the interaction of HIV-1 gp120 with human CD4.
    Tsui P; Sweet RW; Sathe G; Rosenberg M
    J Biol Chem; 1992 May; 267(13):9361-7. PubMed ID: 1533631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptation of human immunodeficiency virus type 1 to cells expressing a binding-deficient CD4 mutant (lysine 46 to aspartic acid).
    Choe HR; Sodroski J
    J Virol; 1995 May; 69(5):2801-10. PubMed ID: 7707502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acid residues of the human immunodeficiency virus type I gp120 critical for the binding of rat and human neutralizing antibodies that block the gp120-sCD4 interaction.
    McKeating JA; Thali M; Furman C; Karwowska S; Gorny MK; Cordell J; Zolla-Pazner S; Sodroski J; Weiss RA
    Virology; 1992 Sep; 190(1):134-42. PubMed ID: 1382339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple effects of CD4 CDR3-related peptide derivatives showing anti-HIV-1 activity on HIV-1 gp120 functions.
    Ohki K; Kimura T; Jones IM; Morita F; Ikuta K
    Vaccine; 1994 Mar; 12(4):343-50. PubMed ID: 8178557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Range of CD4-Bound Conformations of HIV-1 gp120, as Defined Using Conditional CD4-Induced Antibodies.
    Kaplan G; Roitburd-Berman A; Lewis GK; Gershoni JM
    J Virol; 2016 May; 90(9):4481-4493. PubMed ID: 26889042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
    Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of human immunodeficiency virus type 1 entry in the CDR2 loop of the CD4 glycoprotein.
    Brand D; Srinivasan K; Sodroski J
    J Virol; 1995 Jan; 69(1):166-71. PubMed ID: 7983707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding.
    Olshevsky U; Helseth E; Furman C; Li J; Haseltine W; Sodroski J
    J Virol; 1990 Dec; 64(12):5701-7. PubMed ID: 2243375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the tertiary structure of soluble CD4 bound to glycosylated full-length HIVgp120 by chemical modification of arginine residues and mass spectrometric analysis.
    Hager-Braun C; Tomer KB
    Biochemistry; 2002 Feb; 41(6):1759-66. PubMed ID: 11827520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120.
    Turner S; Tizard R; DeMarinis J; Pepinsky RB; Zullo J; Schooley R; Fisher R
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1335-9. PubMed ID: 1741386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of gp120 binding sites on CXCR4 by using CD4-independent human immunodeficiency virus type 2 Env proteins.
    Lin G; Baribaud F; Romano J; Doms RW; Hoxie JA
    J Virol; 2003 Jan; 77(2):931-42. PubMed ID: 12502809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.